Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

NCT05101551 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Talazoparib
DRUG: Topotecan
DRUG: Gemcitabine

Sponsor

Norman J. Lacayo

Collaborators

[object Object]